Advertisement
Advertisement
U.S. Markets open in 8 hrs 18 mins
Advertisement
Advertisement
Advertisement
Advertisement

Novan, Inc. (NOVN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.58+0.16 (+2.16%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.42
Open7.47
Bid0.00 x 1000
Ask0.00 x 1000
Day's Range7.37 - 7.60
52 Week Range4.35 - 25.90
Volume127,964
Avg. Volume525,100
Market Cap1.15B
Beta (5Y Monthly)-0.03
PE Ratio (TTM)N/A
EPS (TTM)-0.30
Earnings DateFeb 25, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est42.50
  • Zacks Small Cap Research

    NOVN: B-SIMPLE4 Safety Data

    By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT B-SIMPLE4 Safety Data In follow up to the June release of topline results for B-SIMPLE4 and additional detail provided in an update on September 9 th , Novan (NASDAQ:NOVN) reported safety data from its pivotal B-SIMPLE4 on September 23 rd . The results were in line with previous trials and SB206 was well tolerated. Treatment

  • GlobeNewswire

    Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206

    – SB206 demonstrates continued favorable safety profile consistent with previous studies and meets Company’s expectations – – Pre-NDA meeting with the FDA, as well as conduct of customary stability testing, targeted for 1H 2022 – – Potential NDA submission on track, targeting Q3 2022 – DURHAM, N.C., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the comprehensive safety data readout as part of the Company’s B-SIMPLE4 pivotal Phase 3 stud

  • GlobeNewswire

    Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

    – Live fireside chat with Paula Brown Stafford, President and Chief Executive Officer of Novan on Tuesday, September 28 at 8:00 AM ET –DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will participate in a fireside chat hosted by Jennifer Kim, Vice President, Equity Research, at the Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, Sep

Advertisement
Advertisement